Egypt Strengthens Local Pharmaceutical Industry at "Africa Health ExCon" 2026
The Egyptian Drug Authority is preparing for a strong participation in the "Africa Health ExCon" 2026 conference and exhibition. This event is considered one of the most prominent health platforms on the African continent, bringing together experts and officials to discuss the future of healthcare and the development of medical industries in the region.
The Authority announced the organization of a keynote panel discussion during the conference titled "Made in Egypt: Transforming Policies into Pharmaceutical Production." This session aims to highlight Egyptian efforts in turning strategic plans and government policies into a tangible reality by increasing the capacity of local factories to produce high-quality medicines and medical supplies.
This step comes within the framework of the Egyptian state's vision to enhance self-sufficiency in essential medicines. Through this conference, Egypt also seeks to confirm its position as a leading regional hub in the pharmaceutical industry, contributing to providing treatment for citizens at affordable prices and opening new horizons for exporting Egyptian products to neighboring African markets.
Discussions during the upcoming session will focus on how to support innovation in the pharmaceutical sector and facilitate regulatory procedures for investors. Additionally, Egyptian success stories in the local manufacturing of vital medicines will be showcased, along with how this expertise can be transferred to other African countries to enhance joint health cooperation on the continent.
In conclusion, "Africa Health ExCon" represents an important opportunity for Egypt to showcase its technological and scientific development in the health field. It is expected that the panel discussions will result in recommendations that contribute to the development of pharmaceutical policies, ensuring a better health future for Egyptians and all African peoples.